title: Tumor-infiltrating lymphocytes in patients with renal-cell carcinoma.
authors.affiliation: Department of Immunology, Cleveland Clinic Foundation, Ohio 44106.
authors.forename: J H
authors.initials: JH
authors.lastname: Finke
authors.forename: R
authors.initials: R
authors.lastname: Tubbs
authors.forename: B
authors.initials: B
authors.lastname: Connelly
authors.forename: E
authors.initials: E
authors.lastname: Pontes
authors.forename: J
authors.initials: J
authors.lastname: Montie
mesh_terms: D002292:Carcinoma, Renal Cell / Q000276:immunology*; D002478:Cells, Cultured; D003602:Cytotoxicity, Immunologic; D006801:Humans; D007376:Interleukin-2 / Q000502:physiology; D007680:Kidney Neoplasms / Q000276:immunology*; D007694:Killer Cells, Natural / Q000276:immunology; D008213:Lymphocyte Activation; D010641:Phenotype; D013601:T-Lymphocytes / Q000276:immunology* / Q000473:pathology; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology; D006377:T-Lymphocytes, Helper-Inducer / Q000276:immunology; D050378:T-Lymphocytes, Regulatory / Q000276:immunology
chemical_list: D007376:Interleukin-2